维普中文期刊产品整合服务
175篇 您的检索式:作者名="TISEO M"
    题名 作者 年代 出处 被引量
1Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer显示文摘Tiseo M Capelletti M De Palma G 2008J Thorac Oncol2008,3,10:1
2Predictive and prognostic significance of neuron-specific eno~ase( NSE )in non-small cell hung cancer 显示文摘Tiseo M Ardizzoni A Cafferata MA 2008Anticencer Res2008,28,:1
3Activity of pemetrexed on hrainmetastases from non- small cell lung cancer显示文摘Bearz A (harassino I Tiseo M 2010Lung Cancer2010,68,2:1
4Pharmacogenetic study of patients with advanced non-small cell lung cancer(NSCLC)treated with second-line pemetrexed or pemetrexed-carboplatin显示文摘Tiseo M Giovannetti E Tibaldi C 2012Lung Cancer2012,78,1:1
5Hospitalization for Pneumonia is Associated With Decreased 1-Year Survival in Patients With Type 2 Diabetes:Results From a Prospective Cohort Study显示文摘Falcone M Tiseo G Russo A 2016Medicine(Baltimore)2016,95,5:1
6Epidermalgrowth factor receptor inhibitors:a new prospective in the treatment of lung cancer显示文摘Tiseo M Loprevite M Ardizzoni A 2004Curr Med Chem Anticancer Agents2004,4,2:1
7Decline in serum carcinoembryonic antigen and cytokeratin 19 fragments during chemotherapy predicts objective response and sur- vival in patients with advanced non-small cell lung cancer 显示文摘Ardizzoni A Cafferata MA Tiseo M 2006Cancer2006,107,12:1
8Epidermal growth factor receptor inhibitors:a new prospective in the treatment of lungcancer显示文摘Tiseo M Loprevite M Ardizzoni A 2004Curr Med Chem Anticancer Agents2004,4,2:1
9Novel targeted approaches in non-snmll cell lung cancer (NSCLC) 显示文摘Ardizzoni A Tiseo M 2006Ann Oncol2006,17,5:1
10Circadian rhythms and cardiovascular health显示文摘Portaluppi F Tiseo R Smolensky M H 2012Sleep Med Rev2012,16,2:1
11First-line treatment in advanced non-small-cell lung cancer:the emerging role of the histologic subtype显示文摘Tiseo M Bartolotti M Gelsomino F 2009Expert Rev Anticancer Ther2009,9,4:1
12EGFR and EML4-ALK gene mutations in NSCLC: a case report of erlotinib-resistant patient with both concomitant mutations显示文摘Tiseo M Gelsomiaino F Boggni D 2011Lung Cancer2011,71,2:1
13Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer显示文摘Ardizzoni A Cafferata MA Tiseo M 0,,12:1
14Meta-analysis Group, Cispla- tin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data me- ta-analysis显示文摘Ardizzoni A Boni L Tiseo M 2007J Natl Cancer Inst2007,99,11:1
15Predictors of gefitinib outcomes in advanced non-small cell lung cancer(NSCLC):study of a comprehensive panel of molecular markers显示文摘Tiseo M Rossi G Capelletti M 2010Lung Cancer2010,67,3:1
16Activity of pemetrexed on brain metastases from non- small cell lung cancer显示文摘BEARZ A GARASSINO I TISEO M 2010Lung Cancer2010,68,2:1
17Activity of Pemetrexed on brain metastases from non - small cell lung cancer 显示文摘Bearz A Garassino I Tiseo M 2010Lung Cancer2010,68,2:1
18Epidermal growth factor receptor inhibitors a new prospective in the treatment of lung cancer显示文摘Tiseo M Loprevite M Ardizzoni A 0,,02:1
19Tumor response to chemotherapy as a surrogate endpoint of survival in advanced non-small cell lung cancer (NSCLC) : results of an individual patients data meta-analysis显示文摘Bruzzi P Sormani M Tiseo ML 2007J Clin Oncol2007,25,18:1
20First-line treatment in advanced non-small-cell lung cancer:the emerging role of the histologic subtype显示文摘TISEO M BARTOLOTTI M CELSOMINO F 2009Expert Rev Anticancer Ther2009,9,4:1
返回顶部 每页显示:
共9页 首页 上一页 第1页 下一页 末页 /9 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费